Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
GRTS | Gritstone bio, Inc. | Jun 24, 2024 | 2 | $0 | 4 | Jun 26, 2024 | PRESIDENT AND CEO, Director |
GRTS | Gritstone bio, Inc. | May 15, 2024 | 3 | -$18.2K | 4 | May 17, 2024 | PRESIDENT AND CEO, Director |
GRTS | Gritstone bio, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | PRESIDENT AND CEO, Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 5, 2023 | 6 | $0 | 4 | Jul 5, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 3, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jun 1, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |
TCRR | TCR2 THERAPEUTICS INC. | Jun 1, 2023 | 6 | $0 | 4 | Jun 1, 2023 | Director |
GRTS | Gritstone bio, Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | President and CEO, Director |
TCRR | TCR2 THERAPEUTICS INC. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 6 | -$90.8K | 4 | Jul 1, 2022 | Director, 10%+ Owner |
GRTS | Gritstone bio, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Apr 20, 2022 | President and CEO, Director |
TCRR | TCR2 THERAPEUTICS INC. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
EPZM | Epizyme, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |
SRRA | Sierra Oncology, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
GRTS | Gritstone bio, Inc. | Jan 7, 2021 | 1 | $0 | 4 | Nov 19, 2021 | President and CEO, Director |